---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000039"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-08-08T23:59:59+00:00"
generated_at: "2026-06-24T03:07:22.169120+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q2 revenue $561M; GAAP net loss $7.5M, adj EPS $1.37; updates FY guidance

## Summary
- Revenue $561.0M vs $321.7M YoY; GAAP net loss $(7.5M) vs income $28.4M.
- Adjusted diluted EPS $1.37 vs $1.88 YoY; Adjusted EBITDA $84.7M vs $66.9M.
- GAAP gross margin fell to 30% from 38% YoY.
- Company updated FY 2022 guidance; specific figures not provided in excerpt.

## SEC filing metadata
- accession: 0000883984-22-000039
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000039/0000883984-22-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000039/icui-20220808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000039
- JSON: https://secwatch.observer/filing/0000883984-22-000039.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.